Inflammatory and cell death pathways in brain and peripheral blood in Parkinson's disease

Beatrice Macchi1, Rosanna Di Paola, Francesca Marino-Merlo

  • 1Department of System Medicine, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy. macchi@uniroma2.it.

Insights

Parkinson disease involves altered brain and blood cell inflammation and cell death pathways. Understanding these molecular changes may reveal new drug targets and biomarkers for Parkinson disease.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Parkinson disease (PD) is characterized by neuroinflammation and neuronal loss.
  • Microglia activation releases inflammatory mediators, contributing to apoptosis.
  • Altered cell death and autophagy pathways are implicated in PD pathogenesis.

Purpose of the Study:

  • To review the molecular dysfunctions in inflammatory and cell death pathways in Parkinson disease.
  • To explore potential therapeutic targets and biomarkers for PD.

Main Methods:

  • Review of existing evidence on molecular pathways in PD.
  • Analysis of inflammatory mediators, cell death signaling, and autophagy.
  • Examination of peripheral blood mononuclear cell alterations in PD patients.

Main Results:

  • Neuroinflammation, apoptosis, and impaired autophagy are key features in PD brain.
  • Peripheral mononuclear cells in PD patients exhibit mitochondrial dysfunction, α-synuclein upregulation, and apoptosis proneness.
  • Alterations in dopamine-related markers are observed in PD patient blood cells.

Conclusions:

  • Dysregulation of inflammatory and cell death pathways is evident in both the brain and periphery in PD.
  • Further understanding of these molecular pathways could lead to novel drug discovery and biomarker identification for Parkinson disease.